Skip to content

Clinical trials

Observational Diabetic Nephropathies trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetic Nephropathies Phase: Observational Country / region: United States Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20051
20101
20111
20132
20141
20161
20171
20192
20201
20215
20223
20232
20242
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Recruiting7
Active, not recruiting7
Terminated1
Not yet recruiting1
Enrolling by invitation1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)6
Renalytix AI, Inc.4
University of Colorado, Denver4
Prokidney2
University of Pennsylvania2
Arkansas Children's Hospital Research Institute1
Duke University1
Goldfinch Bio, Inc.1
Joslin Diabetes Center1
Mayo Clinic1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetic Nephropathies31
Renal Insufficiency, Chronic10
Diabetes Mellitus, Type 28
Diabetes Mellitus7
Kidney Diseases6
Diabetes Complications4
Diabetes Mellitus, Type 14
Obesity3
Albuminuria2
Glomerulosclerosis, Focal Segmental2

Trials

Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.